# Invesco Perpetual

> Invesco Perpetual is a VC fund backing Biotechnology, Medical and Genetics. See 4 investments, check sizes, portfolio. Updated Sep 2026.

- Type: VC Fund
- Total investments: 4
- Last investment: Dec 2018
- Lead investor: 0%
- Last updated: Sep 2026
- X (Twitter): https://www.twitter.com/invescouk
- Website: https://www.invescoperpetual.co.uk/portal/site/ip/home

Invesco Perpetual is a VC fund focused on Biotechnology and Medical. Invesco Perpetual

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 75% |
| Medical | 2 | 50% |
| Genetics | 2 | 50% |
| Health Care | 2 | 50% |
| Biopharma | 1 | 25% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 25% |
| Series C | 1 | 25% |
| Venture - Series Unknown | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Genomics | Genomics plc aiming to lead the genomic transformation of healthcare, to develop and apply sophisticated analyses of massive integrated genomic and phenotypic datasets to learn about human biology and reveal the human wiring diagramThey will lead the way through this challenge, using their expertise and experience to unleash the potential ofgenomics and set the standards by which organisations and patients can benefit from genomic data. | $9.1M | Series B | Dec 09, 2018 | http://www.genomicsplc.com |
| Genomics | Genomics plc aiming to lead the genomic transformation of healthcare, to develop and apply sophisticated analyses of massive integrated genomic and phenotypic datasets to learn about human biology and reveal the human wiring diagramThey will lead the way through this challenge, using their expertise and experience to unleash the potential ofgenomics and set the standards by which organisations and patients can benefit from genomic data. | $32.5M | Series B | Aug 30, 2018 | http://www.genomicsplc.com |
| Oxford Genetics | Oxford Genetics is a UK-based biotechnology company specializing in the production of versatile cloning plasmids for research in academic and biotechnology institutions. They also provide custom cloning and DNA synthesis. All of their products are free of intellectual property restrictions. | $9.7M | Venture - Series Unknown | Aug 21, 2017 | https://www.oxgene.com |
| Kuur Therapeutics | Kuur Therapeutics is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of cytotoxic T cells, called natural killer T cells (NKT cells) and innovative CAR constructengineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors. | $73.7M | Series C | Mar 15, 2017 | https://kuurtx.com/ |

4 of 4 investments shown.

## Co-investors
- [Woodford Investment Management](https://shizune.co/investors/profile/woodford-investment-management) — VC Fund, 3 deals together
- [IP Group](https://shizune.co/investors/profile/ip-group-plc) — VC Fund, 2 deals together
- [Lansdowne Partners](https://shizune.co/investors/profile/lansdowne-partners) — VC Fund, 2 deals together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-science-enterprises) — VC Fund, 2 deals together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-sciences-innovation) — VC Fund, 2 deals together
- [Tanarra Capital](https://shizune.co/investors/profile/tanarra-capital) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Invesco Perpetual invest in?

Invesco Perpetual invests primarily in Biotechnology, Medical and Genetics startups, most often at Series B and Series C stage. Most of the 4 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Invesco Perpetual last invest?

The most recent investment recorded for Invesco Perpetual closed in Dec 2018. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co